Director/PDMR Shareholding
Updated : 16:36
22 October 2021 | |
INSPIRATION HEALTHCARE GROUP PLC
(the "Company")
Directors / PDMR Dealing
The Company has been notified that Toby Foster, VP Strategic Opportunities and a person discharging managerial responsibility ("PDMR") in the Company, on Thursday 21st October sold 25,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares").
Following the sale, Mr Foster retains an interest in 3,255,283 Ordinary Shares, representing approximately 4.78 per cent. of the Company's issued ordinary share capital. Mr Foster has indicated to the Company that he has no intention to sell further shares at this time.
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||||||
a. | Name | Toby Foster | |||||||||
2 | Reason for notification | ||||||||||
a. | Position/Status | VP Strategic Opportunities of Inspiration Healthcare Group plc | |||||||||
b. | Initial notification/ Amendment | Initial Notification | |||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a. | Name | INSPIRATION HEALTHCARE GROUP PLC
| |||||||||
b. | LEI | 213800GKFT3ENAPMDL15 | |||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a. | Description of the financial instrument, type of instrument | Ordinary Shares of 10p each
ISIN: GB00BXDZL105 | |||||||||
b. | Nature of the transaction | Sale of Ordinary Shares | |||||||||
c. | Price(s) and volume(s) | ||||||||||
Price(s) | Volume(s) | Date | |||||||||
138p
| 25,000
| 21st October 2021 | |||||||||
| |||||||||||
d. | Aggregated information - Aggregated Volume - Price
|
| |||||||||
e. | Date of the transaction | 21st October 2021 | |||||||||
f. | Place of the transaction | XLON (AIM) | |||||||||
Enquiries:
Inspiration Healthcare Group plc | Tel: 01455 840 555
|
Cenkos Securities plc - Nominated Adviser & Broker | Tel: 0207 397 8900
|
Cadogan PR | Tel: 07771 713 608
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspirationhealthcaregroup.plc.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.